CompletedPhase 3NCT00737672

GORE VIABAHN Endoprosthesis Versus Percutaneous Transluminal Angioplasty (PTA) to Revise AV Grafts in Hemodialysis

Studying Complication in hemodialysis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
W.L.Gore & Associates
Principal Investigator
Tom Vesely, MD, M.D
Vascular Access Center; Frontenac, MO
Intervention
GORE VIABAHN Endoprosthesis with PROPATEN Bioactive Surface(device)
Enrollment
293 enrolled
Eligibility
18 years · All sexes
Timeline
20082013

Study locations (29)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00737672 on ClinicalTrials.gov

Other trials for Complication in hemodialysis

Additional recruiting or active studies for the same condition.

See all trials for Complication in hemodialysis

← Back to all trials